Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA.
Department of Surgery, Mayo Clinic, Rochester, MN, USA.
J Plast Reconstr Aesthet Surg. 2023 Oct;85:515-522. doi: 10.1016/j.bjps.2023.02.020. Epub 2023 Apr 30.
Masculinizing chest wall gender-affirming surgery is an important element in the treatment of gender dysphoria. In this study, we report an institutional series of subcutaneous mastectomies and aim to identify the risk factors for major complications and revision surgery. A retrospective review of consecutive patients who underwent primary masculinizing top surgery via subcutaneous mastectomy at our institution through July 2021 was performed. Demographics and clinical characteristics were recorded as well as major complications and revision surgeries. Time-to-event analyses were performed to assess predictors of major complications and revision surgery. Seventy-three consecutive patients (146 breasts) were included. The mean age and the mean body mass index were 25.2 ± 7 years and 27.6 ± 6.5 kg/m, respectively. The mean follow-up time was 7.9 ± 7.5 months. None of the patients had a history of chest wall radiation or breast surgery. Double incision with free nipple grafting was the most common technique (n = 130, 89%), followed by periareolar semicircular incision (n = 16, 11%). The mean resection weight was 524.7 ± 377.7 g. Concomitant suction-assisted lipectomy was performed in 48 (32.9%) cases. The rate of major complications was 2.7%. Revision surgery was performed in 8 (5.4%) cases. Concomitant liposuction was significantly associated with a lower rate of revision surgery (p = 0.026). Masculinizing chest wall gender-affirming surgery is a safe procedure with a low rate of revision. Concomitant liposuction significantly reduced the need of revision surgery. Future studies utilizing patient-reported outcomes are still required to better assess the success of this procedure.
男性化胸壁性别肯定手术是治疗性别焦虑症的重要元素。在这项研究中,我们报告了一系列机构皮下乳房切除术,并旨在确定主要并发症和修正手术的风险因素。对我们机构通过皮下乳房切除术进行原发性男性化顶级手术的连续患者进行了回顾性审查,截至 2021 年 7 月。记录了人口统计学和临床特征,以及主要并发症和修正手术。进行时间事件分析以评估主要并发症和修正手术的预测因素。共纳入 73 例连续患者(146 例乳房)。平均年龄和平均体重指数分别为 25.2 ± 7 岁和 27.6 ± 6.5 kg/m。平均随访时间为 7.9 ± 7.5 个月。所有患者均无胸壁放疗或乳房手术史。双切口游离乳头移植术是最常见的技术(n = 130,89%),其次是乳晕半环形切口(n = 16,11%)。平均切除重量为 524.7 ± 377.7 g。48 例(32.9%)患者同时进行吸脂辅助脂肪切除术。主要并发症发生率为 2.7%。8 例(5.4%)患者行修正手术。同时吸脂术与较低的修正手术率显著相关(p = 0.026)。男性化胸壁性别肯定手术是一种安全的手术,修正手术率低。同时吸脂术显著降低了修正手术的需要。未来仍需要利用患者报告的结果进行研究,以更好地评估该手术的成功。